[Can argon laser photocoagulation control senile macular degeneration?].
This study comprises 20 eyes with age related macular degeneration and subsequent subretinal neovascular membranes in which green argon laser photocoagulation was performed. After a follow-up ranging from 3 to 36 months (mean follow-up period 14.5 months), 7 (35%) of these eyes kept on having visual loss, 9 (45%) of them retained the initial vision and 4 (20%) improved (2 lines or more). Despite the small number of cases we consider our results quite encouraging and this specific therapy could be performed even on the purpose to obtain the minimum possible final central scotoma.
Stangos
N
N
Clinique Kianous Stavros, Département d'Ophtalmologie, Thessalonique, Grèce.
Voutas
S
S
Kara Batakis
V
V
Rassoglou
P
P
Anastasiadis
D
D
D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000502:physiology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D053685:Laser Therapy; D008028:Light Coagulation; D008268:Macular Degeneration / Q000503:physiopathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D014792:Visual Acuity
La photocoagulation au laser monochromatique vert peut-elle contrôler la dégénérescence maculaire liée à l'âge?